APO Research
Talk to an analyst

APO RESEARCH · REPORT

Small Molecule Innovator CDMO

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Small Molecule Innovator CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025196 pages

Choose your research edition.

Industry ResearchSmall Molecule Innovator CDMO Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Small Molecule Innovator CDMO Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Small Molecule Innovator CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Small Molecule Innovator CDMO Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Small Molecule Innovator CDMO Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Small Molecule Innovator CDMO market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Small Molecule Innovator CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Small Molecule Innovator CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Small Molecule Innovator CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Small Molecule Innovator CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Small Molecule Innovator CDMO include Boehringer Ingelheim, Cambrex Corporation, CATALENT, CordenPharma International, Covance, Piramal Pharma Solutions, Recipharm AB, Siegfried Holding AG and Lonza Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Small Molecule Innovator CDMO market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Small Molecule Innovator CDMO and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Small Molecule Innovator CDMO sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Small Molecule Innovator CDMO market size, projected growth trends, production technologies, key applications, and end-use industries.

Small Molecule Innovator CDMO Segment by Company

Boehringer Ingelheim

Cambrex Corporation

CATALENT

CordenPharma International

Covance

Piramal Pharma Solutions

Recipharm AB

Siegfried Holding AG

Lonza Group

Thermo Fisher Scientific

Small Molecule Innovator CDMO Segment by Type

Oral Solid Dosage Form

Semi-solid Dosage Form

Small Molecule Innovator CDMO Segment by Application

Pharmaceutical and Biotech Companies

Academic and Research Institutions

Others

Small Molecule Innovator CDMO Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Small Molecule Innovator CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Small Molecule Innovator CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Small Molecule Innovator CDMO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Small Molecule Innovator CDMO market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Small Molecule Innovator CDMO manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Small Molecule Innovator CDMO in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Small Molecule Innovator CDMO in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Small Molecule Innovator CDMO Industry Trends Table 2. Small Molecule Innovator CDMO Industry Drivers Table 3. Small Molecule Innovator CDMO Industry Opportunities and Challenges Table 4. Small Molecule Innovator CDMO Industry Restraints Table 5. Global Small Molecule Innovator CDMO Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Small Molecule Innovator CDMO Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Small Molecule Innovator CDMO Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Small Molecule Innovator CDMO Sales Market Share by Manufacturers Table 9. Global Small Molecule Innovator CDMO Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Small Molecule Innovator CDMO Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Small Molecule Innovator CDMO Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Small Molecule Innovator CDMO Manufacturers, Product Type & Application Table 13. Global Small Molecule Innovator CDMO Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Small Molecule Innovator CDMO by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Solid Dosage Form Table 17. Major Manufacturers of Semi-solid Dosage Form Table 18. Global Small Molecule Innovator CDMO Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Small Molecule Innovator CDMO Sales by Type (2021-2026) & (K Units) Table 20. Global Small Molecule Innovator CDMO Sales by Type (2027-2032) & (K Units) Table 21. Global Small Molecule Innovator CDMO Sales Market Share by Type (2021-2026) Table 22. Global Small Molecule Innovator CDMO Sales Market Share by Type (2027-2032) Table 23. Global Small Molecule Innovator CDMO Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Small Molecule Innovator CDMO Revenue by Type (2021-2026) & (K Units) Table 25. Global Small Molecule Innovator CDMO Revenue by Type (2027-2032) & (K Units) Table 26. Global Small Molecule Innovator CDMO Revenue Market Share by Type (2021-2026) Table 27. Global Small Molecule Innovator CDMO Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Pharmaceutical and Biotech Companies Table 29. Major Manufacturers of Academic and Research Institutions Table 30. Major Manufacturers of Others Table 31. Global Small Molecule Innovator CDMO Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Small Molecule Innovator CDMO Sales by Application (2021-2026) & (K Units) Table 33. Global Small Molecule Innovator CDMO Sales by Application (2027-2032) & (K Units) Table 34. Global Small Molecule Innovator CDMO Sales Market Share by Application (2021-2026) Table 35. Global Small Molecule Innovator CDMO Sales Market Share by Application (2027-2032) Table 36. Global Small Molecule Innovator CDMO Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Small Molecule Innovator CDMO Revenue by Application (2021-2026) & (K Units) Table 38. Global Small Molecule Innovator CDMO Revenue by Application (2027-2032) & (K Units) Table 39. Global Small Molecule Innovator CDMO Revenue Market Share by Application (2021-2026) Table 40. Global Small Molecule Innovator CDMO Revenue Market Share by Application (2027-2032) Table 41. Global Small Molecule Innovator CDMO Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Small Molecule Innovator CDMO Sales by Region (2021-2026) & (K Units) Table 43. Global Small Molecule Innovator CDMO Sales Market Share by Region (2021-2026) Table 44. Global Small Molecule Innovator CDMO Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Small Molecule Innovator CDMO Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Small Molecule Innovator CDMO Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Small Molecule Innovator CDMO Sales by Country (2021-2026) & (K Units) Table 48. North America Small Molecule Innovator CDMO Sales by Country (2027-2032) & (K Units) Table 49. Europe Small Molecule Innovator CDMO Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Small Molecule Innovator CDMO Sales by Country (2021-2026) & (K Units) Table 51. Europe Small Molecule Innovator CDMO Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Small Molecule Innovator CDMO Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Small Molecule Innovator CDMO Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Small Molecule Innovator CDMO Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Small Molecule Innovator CDMO Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Small Molecule Innovator CDMO Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Small Molecule Innovator CDMO Sales by Country (2027-2032) & (K Units) Table 58. Global Small Molecule Innovator CDMO Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Small Molecule Innovator CDMO Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Small Molecule Innovator CDMO Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Small Molecule Innovator CDMO Revenue Market Share by Region (2021-2026) Table 62. Global Small Molecule Innovator CDMO Revenue Market Share by Region (2027-2032) Table 63. Boehringer Ingelheim Company Information Table 64. Boehringer Ingelheim Business Overview Table 65. Boehringer Ingelheim Small Molecule Innovator CDMO Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Boehringer Ingelheim Small Molecule Innovator CDMO Product Portfolio Table 67. Boehringer Ingelheim Recent Development Table 68. Cambrex Corporation Company Information Table 69. Cambrex Corporation Business Overview Table 70. Cambrex Corporation Small Molecule Innovator CDMO Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Cambrex Corporation Small Molecule Innovator CDMO Product Portfolio Table 72. Cambrex Corporation Recent Development Table 73. CATALENT Company Information Table 74. CATALENT Business Overview Table 75. CATALENT Small Molecule Innovator CDMO Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. CATALENT Small Molecule Innovator CDMO Product Portfolio Table 77. CATALENT Recent Development Table 78. CordenPharma International Company Information Table 79. CordenPharma International Business Overview Table 80. CordenPharma International Small Molecule Innovator CDMO Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. CordenPharma International Small Molecule Innovator CDMO Product Portfolio Table 82. CordenPharma International Recent Development Table 83. Covance Company Information Table 84. Covance Business Overview Table 85. Covance Small Molecule Innovator CDMO Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Covance Small Molecule Innovator CDMO Product Portfolio Table 87. Covance Recent Development Table 88. Piramal Pharma Solutions Company Information Table 89. Piramal Pharma Solutions Business Overview Table 90. Piramal Pharma Solutions Small Molecule Innovator CDMO Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Piramal Pharma Solutions Small Molecule Innovator CDMO Product Portfolio Table 92. Piramal Pharma Solutions Recent Development Table 93. Recipharm AB Company Information Table 94. Recipharm AB Business Overview Table 95. Recipharm AB Small Molecule Innovator CDMO Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Recipharm AB Small Molecule Innovator CDMO Product Portfolio Table 97. Recipharm AB Recent Development Table 98. Siegfried Holding AG Company Information Table 99. Siegfried Holding AG Business Overview Table 100. Siegfried Holding AG Small Molecule Innovator CDMO Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Siegfried Holding AG Small Molecule Innovator CDMO Product Portfolio Table 102. Siegfried Holding AG Recent Development Table 103. Lonza Group Company Information Table 104. Lonza Group Business Overview Table 105. Lonza Group Small Molecule Innovator CDMO Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Lonza Group Small Molecule Innovator CDMO Product Portfolio Table 107. Lonza Group Recent Development Table 108. Thermo Fisher Scientific Company Information Table 109. Thermo Fisher Scientific Business Overview Table 110. Thermo Fisher Scientific Small Molecule Innovator CDMO Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Thermo Fisher Scientific Small Molecule Innovator CDMO Product Portfolio Table 112. Thermo Fisher Scientific Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Small Molecule Innovator CDMO Distributors List Table 116. Small Molecule Innovator CDMO Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Small Molecule Innovator CDMO Product Image Figure 2. Global Small Molecule Innovator CDMO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Small Molecule Innovator CDMO Market Size (2021-2032) & (US$ Million) Figure 4. Global Small Molecule Innovator CDMO Sales (2021-2032) & (K Units) Figure 5. Global Small Molecule Innovator CDMO Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Small Molecule Innovator CDMO Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Solid Dosage Form Image Figure 9. Semi-solid Dosage Form Image Figure 10. Global Small Molecule Innovator CDMO Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Small Molecule Innovator CDMO Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Small Molecule Innovator CDMO Sales Market Share by Type (2021-2032) Figure 13. Global Small Molecule Innovator CDMO Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Small Molecule Innovator CDMO Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Small Molecule Innovator CDMO Revenue Market Share by Type (2021-2032) Figure 16. Pharmaceutical and Biotech Companies Image Figure 17. Academic and Research Institutions Image Figure 18. Others Image Figure 19. Global Small Molecule Innovator CDMO Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Small Molecule Innovator CDMO Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Small Molecule Innovator CDMO Sales Market Share by Application (2021-2032) Figure 22. Global Small Molecule Innovator CDMO Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Small Molecule Innovator CDMO Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Small Molecule Innovator CDMO Revenue Market Share by Application (2021-2032) Figure 25. North America Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Small Molecule Innovator CDMO Sales Market Share by Country (2021-2032) Figure 27. U.S. Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Small Molecule Innovator CDMO Sales Market Share by Country (2021-2032) Figure 32. Germany Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Small Molecule Innovator CDMO Sales Market Share by Country (2021-2032) Figure 39. China Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Small Molecule Innovator CDMO Sales Market Share by Country (2021-2032) Figure 47. Brazil Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Small Molecule Innovator CDMO Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Small Molecule Innovator CDMO Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Small Molecule Innovator CDMO Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Small Molecule Innovator CDMO Revenue (2021-2032) & (US$ Million) Figure 58. North America Small Molecule Innovator CDMO Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Small Molecule Innovator CDMO Revenue (2021-2032) & (US$ Million) Figure 60. Europe Small Molecule Innovator CDMO Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Small Molecule Innovator CDMO Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Small Molecule Innovator CDMO Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Small Molecule Innovator CDMO Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Small Molecule Innovator CDMO Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Small Molecule Innovator CDMO Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Small Molecule Innovator CDMO Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Solid Dosage Form
  • Semi-solid Dosage Form
Applications
  • Pharmaceutical and Biotech Companies
  • Academic and Research Institutions
  • Others
Companies covered
  • Boehringer Ingelheim
  • Cambrex Corporation
  • CATALENT
  • CordenPharma International
  • Covance
  • Piramal Pharma Solutions
  • Recipharm AB
  • Siegfried Holding AG
  • Lonza Group
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Small Molecule Innovator CDMO Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Small Molecule Innovator CDMO Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Small Molecule Innovator CDMO Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Small Molecule Innovator CDMO Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Small Molecule Innovator CDMO Market Dynamics
  1. 2.1 Small Molecule Innovator CDMO Industry Trends
  2. 2.2 Small Molecule Innovator CDMO Industry Drivers
  3. 2.3 Small Molecule Innovator CDMO Industry Opportunities and Challenges
  4. 2.4 Small Molecule Innovator CDMO Industry Restraints
3 Small Molecule Innovator CDMO Market by Manufacturers
  1. 3.1 Global Small Molecule Innovator CDMO Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Small Molecule Innovator CDMO Sales by Manufacturers (2021-2026)
  3. 3.3 Global Small Molecule Innovator CDMO Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Small Molecule Innovator CDMO Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Small Molecule Innovator CDMO Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Small Molecule Innovator CDMO Manufacturers, Product Type & Application
  7. 3.7 Global Small Molecule Innovator CDMO Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Small Molecule Innovator CDMO Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Small Molecule Innovator CDMO Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Small Molecule Innovator CDMO Tier 1, Tier 2, and Tier 3
4 Small Molecule Innovator CDMO Market by Type
  1. 4.1 Small Molecule Innovator CDMO Type Introduction
  2. 4.1.1 Oral Solid Dosage Form
  3. 4.1.2 Semi-solid Dosage Form
  4. 4.2 Global Small Molecule Innovator CDMO Sales by Type
  5. 4.2.1 Global Small Molecule Innovator CDMO Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Small Molecule Innovator CDMO Sales by Type (2021-2032)
  7. 4.2.3 Global Small Molecule Innovator CDMO Sales Market Share by Type (2021-2032)
  8. 4.3 Global Small Molecule Innovator CDMO Revenue by Type
  9. 4.3.1 Global Small Molecule Innovator CDMO Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Small Molecule Innovator CDMO Revenue by Type (2021-2032)
  11. 4.3.3 Global Small Molecule Innovator CDMO Revenue Market Share by Type (2021-2032)
5 Small Molecule Innovator CDMO Market by Application
  1. 5.1 Small Molecule Innovator CDMO Application Introduction
  2. 5.1.1 Pharmaceutical and Biotech Companies
  3. 5.1.2 Academic and Research Institutions
  4. 5.1.3 Others
  5. 5.2 Global Small Molecule Innovator CDMO Sales by Application
  6. 5.2.1 Global Small Molecule Innovator CDMO Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Small Molecule Innovator CDMO Sales by Application (2021-2032)
  8. 5.2.3 Global Small Molecule Innovator CDMO Sales Market Share by Application (2021-2032)
  9. 5.3 Global Small Molecule Innovator CDMO Revenue by Application
  10. 5.3.1 Global Small Molecule Innovator CDMO Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Small Molecule Innovator CDMO Revenue by Application (2021-2032)
  12. 5.3.3 Global Small Molecule Innovator CDMO Revenue Market Share by Application (2021-2032)
6 Global Small Molecule Innovator CDMO Sales by Region
  1. 6.1 Global Small Molecule Innovator CDMO Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Small Molecule Innovator CDMO Sales by Region (2021-2032)
  3. 6.2.1 Global Small Molecule Innovator CDMO Sales by Region (2021-2026)
  4. 6.2.2 Global Small Molecule Innovator CDMO Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Small Molecule Innovator CDMO Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Small Molecule Innovator CDMO Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Small Molecule Innovator CDMO Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Small Molecule Innovator CDMO Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Small Molecule Innovator CDMO Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Small Molecule Innovator CDMO Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Small Molecule Innovator CDMO Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Small Molecule Innovator CDMO Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Small Molecule Innovator CDMO Revenue by Region
  1. 7.1 Global Small Molecule Innovator CDMO Revenue by Region
  2. 7.1.1 Global Small Molecule Innovator CDMO Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Small Molecule Innovator CDMO Revenue by Region (2021-2026)
  4. 7.1.3 Global Small Molecule Innovator CDMO Revenue by Region (2027-2032)
  5. 7.1.4 Global Small Molecule Innovator CDMO Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Small Molecule Innovator CDMO Revenue (2021-2032)
  8. 7.2.2 North America Small Molecule Innovator CDMO Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Small Molecule Innovator CDMO Revenue (2021-2032)
  11. 7.3.2 Europe Small Molecule Innovator CDMO Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Small Molecule Innovator CDMO Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Small Molecule Innovator CDMO Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Small Molecule Innovator CDMO Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Small Molecule Innovator CDMO Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Small Molecule Innovator CDMO Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Small Molecule Innovator CDMO Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Cambrex Corporation
  8. 8.2.1 Cambrex Corporation Company Information
  9. 8.2.2 Cambrex Corporation Business Overview
  10. 8.2.3 Cambrex Corporation Small Molecule Innovator CDMO Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cambrex Corporation Small Molecule Innovator CDMO Product Portfolio
  12. 8.2.5 Cambrex Corporation Recent Developments
  13. 8.3 CATALENT
  14. 8.3.1 CATALENT Company Information
  15. 8.3.2 CATALENT Business Overview
  16. 8.3.3 CATALENT Small Molecule Innovator CDMO Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CATALENT Small Molecule Innovator CDMO Product Portfolio
  18. 8.3.5 CATALENT Recent Developments
  19. 8.4 CordenPharma International
  20. 8.4.1 CordenPharma International Company Information
  21. 8.4.2 CordenPharma International Business Overview
  22. 8.4.3 CordenPharma International Small Molecule Innovator CDMO Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CordenPharma International Small Molecule Innovator CDMO Product Portfolio
  24. 8.4.5 CordenPharma International Recent Developments
  25. 8.5 Covance
  26. 8.5.1 Covance Company Information
  27. 8.5.2 Covance Business Overview
  28. 8.5.3 Covance Small Molecule Innovator CDMO Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Covance Small Molecule Innovator CDMO Product Portfolio
  30. 8.5.5 Covance Recent Developments
  31. 8.6 Piramal Pharma Solutions
  32. 8.6.1 Piramal Pharma Solutions Company Information
  33. 8.6.2 Piramal Pharma Solutions Business Overview
  34. 8.6.3 Piramal Pharma Solutions Small Molecule Innovator CDMO Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Piramal Pharma Solutions Small Molecule Innovator CDMO Product Portfolio
  36. 8.6.5 Piramal Pharma Solutions Recent Developments
  37. 8.7 Recipharm AB
  38. 8.7.1 Recipharm AB Company Information
  39. 8.7.2 Recipharm AB Business Overview
  40. 8.7.3 Recipharm AB Small Molecule Innovator CDMO Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Recipharm AB Small Molecule Innovator CDMO Product Portfolio
  42. 8.7.5 Recipharm AB Recent Developments
  43. 8.8 Siegfried Holding AG
  44. 8.8.1 Siegfried Holding AG Company Information
  45. 8.8.2 Siegfried Holding AG Business Overview
  46. 8.8.3 Siegfried Holding AG Small Molecule Innovator CDMO Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Siegfried Holding AG Small Molecule Innovator CDMO Product Portfolio
  48. 8.8.5 Siegfried Holding AG Recent Developments
  49. 8.9 Lonza Group
  50. 8.9.1 Lonza Group Company Information
  51. 8.9.2 Lonza Group Business Overview
  52. 8.9.3 Lonza Group Small Molecule Innovator CDMO Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lonza Group Small Molecule Innovator CDMO Product Portfolio
  54. 8.9.5 Lonza Group Recent Developments
  55. 8.10 Thermo Fisher Scientific
  56. 8.10.1 Thermo Fisher Scientific Company Information
  57. 8.10.2 Thermo Fisher Scientific Business Overview
  58. 8.10.3 Thermo Fisher Scientific Small Molecule Innovator CDMO Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Thermo Fisher Scientific Small Molecule Innovator CDMO Product Portfolio
  60. 8.10.5 Thermo Fisher Scientific Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Small Molecule Innovator CDMO Value Chain Analysis
  2. 9.1.1 Small Molecule Innovator CDMO Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Small Molecule Innovator CDMO Production Mode & Process
  6. 9.2 Small Molecule Innovator CDMO Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Small Molecule Innovator CDMO Distributors
  9. 9.2.3 Small Molecule Innovator CDMO Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst